An observational study for evaluating predictability of the Vulnerable Elders Survey (VES) -13 for cognitive impairment in elderly patients with advanced cancer
Project/Area Number |
25460896
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
General internal medicine(including psychosomatic medicine)
|
Research Institution | Nagoya University |
Principal Investigator |
Ando Masahiko 名古屋大学, 医学部附属病院, 准教授 (10322736)
|
Co-Investigator(Kenkyū-buntansha) |
長谷 哲成 名古屋大学, 医学部附属病院, 助教 (30621635)
森瀬 昌宏 名古屋大学, 医学部附属病院, 病院助教 (00612756)
|
Project Period (FY) |
2013-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 高齢者 / がん / 化学療法 / 機能評価 / アウトカム予測 |
Outline of Final Research Achievements |
We examined an association between treatment outcomes and Vulnerable Elders Survey-13 (VES-13), Mini-Mental State Examination (MMSE), and Charlson Comorbidity Index (CCI) in 101 patients aged 65 years or older with advanced non-small cell lung cancer who received carboplatin and pemetrexed as a first-line chemotherapy. In the Cox proportion hazards model including age, sex, disease stage, and performance status as covariates, VES-13 showed significant association with overall survival. Performance status, VES-13, and CCI had a significant association with progression-free survival. In the logistic regression analysis, performance status, MMSE, and CCI demonstrated a significant association with antitumor response. Age was not significantly correlated with any treatment outcome. These results suggest the importance of geriatric assessment in predicting treatment outcomes in elderly patients in advanced non-small cell lung cancer receiving a standard combination chemotherapy.
|
Report
(5 results)
Research Products
(51 results)
-
-
[Journal Article] A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG14092016
Author(s)
Kozo Kataoka, Hiroya Takeuchi, Junki Mizusawa, Masahiko Ando, Yasuhiro Tsubosa, Kazuo Koyanagi, Hiroyuki Daiko, Satoru Matsuda, Kenichi Nakamura, Ken Kato, and Yuko Kitagawa
-
Journal Title
Jpn J Clin Oncol
Volume: 46
Issue: 2
Pages: 174-177
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Prospective analysis on oncogenic driver mutations and environmental factors: Japan Molecular Epidemiology for lung cancer study (JME)2016
Author(s)
2.Tomoya Kawaguchi, Yasuhiro Koh, Masahiko Ando, Norimasa Ito, Sadanori Takeo, Hirofumi Adachi, Tsutomu Tagawa, Seiichi Kakegawa, Motohiro Yamashita, Kazuhiko Kataoka, Yukito Ichinose, Yukiyasu Takeuchi, Masakuni Serizawa, Akihiro Tamiya, Shigeki Shimizu, Naoki Yoshimoto, Akihito Kubo, Shun-ichi Isa, Hideo Saka
-
Journal Title
J Clin Oncol
Volume: 34
Issue: 19
Pages: 2247-2257
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study2016
Author(s)
Kota Takahashi, Hiroyuki Taniguchi, Masahiko Ando, Koji Sakamoto, Yasuhiro Kondoh, Naohiro Watanabe, Tomoki Kimura, Kensuke Kataoka, Atsushi Suzuki, Satoru Ito, and Yoshinori Hasegawa
-
Journal Title
BMC Pulm Med
Volume: 16
Issue: 1
Pages: 55-55
DOI
Related Report
Peer Reviewed
-
[Journal Article] Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?2016
Author(s)
1.Toshio Kato, Masahiro Morise, Masahiko Ando, Eiji Kojima, Tomohiko Ogasawara, Ryujiro Suzuki, Joe Shindoh, Masami Matsumoto, Yasuteru Sugino, Masahiro Ogawa, Yasuhiro Nozaki, Tetsunari Hase, Masashi Kondo, Hiroshi Saito, and Yoshinori Hasegawa
-
Journal Title
J Cancer Res Clin Oncol
Volume: 142
Issue: 7
Pages: 1629-1640
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Factors Affecting the Diagnostic Yield of Transbronchial Biopsy Using Endobronchial Ultrasonography with a Guide Sheath in Peripheral Lung Cancer2016
Author(s)
Shotaro Okachi, Naoyuki Imai, Kazuyoshi Imaizumi, Shingo Iwano, Masahiko Ando, Tetsunari Hase, Hiromichi Aso, Masahiro Morise, Keiko Wakahara, Satoru Ito, Naozumi Hashimoto, Mitsuo Sato, Masashi Kondo, and Yoshinori Hasegawa
-
Journal Title
Internal Medicine
Volume: 55
Issue: 13
Pages: 1705-1712
DOI
NAID
ISSN
0918-2918, 1349-7235
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Phase II Study of Carboplatin and Pemetrexed in Advanced EGFR-wild-type Non-squamous Non-small Cell Lung Cancer: The Central Japan Lung Study Group Trial 09062016
Author(s)
Tomoki Kimura, Hiroyuki Taniguchi, Joe Shindo, Tomohiko Ogasawara, Eiji Kojima, Yoshinori Hasegawa, Masashi Yamamoto, Naohiro Watanabe, Hideo Saka, Yoshihito Kogure, Ryujiro Suzuki, Masahiko Ando, Masashi Kondo, and Hiroshi Saito
-
Journal Title
Anticancer Res
Volume: 36
Pages: 1767-1772
Related Report
Peer Reviewed
-
-
[Journal Article] Association of Beck Depression Inventory score and Temperament and Character Inventory-125 in patients with eating disorders and severe malnutrition2015
Author(s)
1.Tanakab S, Yoshida K, Katayama H, Kohmura K, Kawano N, Imaeda M, Kato S, Ando M, Aleksic B, Nishioka K, and Ozaki N
-
Journal Title
J Eat Disord
Volume: 3
Issue: 1
Pages: 36-36
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] An increase of anti-myeloperoxidase (MPO) anti-neutrophil cytoplasmic antibody (ANCA) in renal ANCA-associated vasculitis patients is associated with a risk to relapse2015
Author(s)
1.Yamaguchi M, Ando M, Kato S, Katsuno T, Kato N, Kosugi T, Sato W Tsuboi N, Yasuda Y, Mizuno M, Ito Y, Matsuo S, and Maruyama S
-
Journal Title
J Rheumatol
Volume: 42
Issue: 10
Pages: 1853-1860
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Relationship between social support during pregnancy and postpartum depressive state: a prospective cohort study2015
Author(s)
1.Morikawa M, Okada T, Ando M, Aleksic B, Kunimoto S, Nakamura Y, Kubota C, Uno Y, Tamaji A, Hayakawa N, Furumura K, Shiino T, Morita T, Ishikawa N, Ohoka H, Usui H, Banno N, Murase S, Goto S, Kanai A, Masuda T, and Ozaki N
-
Journal Title
Sci Rep
Volume: 5
Issue: 1
Pages: 10520-10520
DOI
Related Report
Peer Reviewed
-
[Journal Article] Risk Factors for 30-Day Mortality in Patients with Pneumonia Who Receive Appropriate Initial Antibiotics: An Observational Cohort Study2015
Author(s)
1.Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, and Hasegawa Y
-
Journal Title
Lancet Infect Dis
Volume: 15
Issue: 9
Pages: 1055-1065
DOI
Related Report
Peer Reviewed
-
[Journal Article] Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: A multicenter, randomized clinical trial2015
Author(s)
1.Kato S, Maruyama S, Makino H, Wada J, Ogawa D, Uzu T, Araki H, Koya D, Kanasaki K, Oiso Y, Goto M, Nishiyama A, Kobori H, Imai E, Ando M, and Matsuo S
-
Journal Title
Clin Experim Nephrol
Volume: 19
Issue: 6
Pages: 1098-1106
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Identification of an interaction between VWF rs7965413 and platelet count as a novel risk marker for metabolic syndrome: an extensive search of candidate polymorphisms in a case-control study2015
Author(s)
1.Nakatochi M Ushida Y Yasuda Y, Yoshida Y, Kawai S, Kato R, Nakashima T, Iwata M, Kuwatsuka Y, Ando M, Hamajima N, Kondo T, Oda H, Hayashi M, Kato S, Yamaguchi M, Maruyama S, Matsuo S, and Honda H
-
Journal Title
PLoS One
Volume: 10
Issue: 2
Pages: e0117591-e0117591
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Molecular epidemiological characteristics of Klebsiella pneumoniae associated with bacteremia among patients with pneumonia.2015
Author(s)
R. Ito, Y. Shindo, D. Kobayashi, M. Ando, W. Jin, J. Wachino, K. Yamada, K. Kimura, T. Yagi, Y. Hasegawa, Y. Arakawa
-
Journal Title
J Clin Microbiol.
Volume: 53
Issue: 3
Pages: 879-889
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids.2015
Author(s)
Sato Y, Sato W, Maruyama S, Wilcox CS, Falck JR, Masuda T, Kosugi T, Kojima H, Maeda K, Furuhashi K, Ando M, Imai E, Matsuo S, Kadomatsu K.
-
Journal Title
J Am Soc Nephrol
Volume: inpress
Issue: 8
Pages: 1806-1815
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Long-term quality of life after laparoscopic distal gastrectomy for early gastric cancer: results of a prospective multi-institutional comparative trial2015
Author(s)
1.Misawa K, Fujiwara M, Ando M, Ito S, Mochizuki Y, Ito Y, Onishi E, Ishigure K, Morioka Y, Takase T, Watanabe T, Yamamura Y, Morita S, and Kodera Y
-
Journal Title
Gastric Cancer
Volume: 18
Issue: 2
Pages: 417-425
DOI
NAID
Related Report
Peer Reviewed
-
-
-
[Journal Article] Ultra-sensitive detection of the pretreatment EGFR T790M mutation in non-small-cell lung cancer patients with an EGFR-activating mutation using picodroplet digital PCR.2015
Author(s)
Watanabe M, Kawaguchi T, Isa S-I, Ando M, Tamiya A, Kubo A, Saka H, Takeo S, Adachi H, Tagawa T, Kakegawa S, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Sakamoto K, Matsumura A, Koh Y.
-
Journal Title
Clin Cancer Res
Volume: in press
Issue: 15
Pages: 3552-3560
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Randomized phase III trial comparing weekly docetaxel plus cisplatin and docetaxel monotherapy every 3 weeks in elderly patients with advanced non-small-cell lung cancer: the intergroup trial JCOG0803/WJOG4307L2015
Author(s)
Abe T, Takeda K, Ohe Y, Kudoh S, Ichinose Y, Okamoto H, Yamamoto N, Yoshioka H , Koichi Minato, Sawa T, Iwamoto Y, Saka H, Mizusawa J, Shibata T, Nakamura S, Ando M, Yokoyama A, Nakagawa K, Saijo N, and Tamura T
-
Journal Title
J Clin Oncol
Volume: 33
Issue: 6
Pages: 575-581
DOI
Related Report
Peer Reviewed
-
[Journal Article] Therapeutic and Preventive Antiemetic Effect of Aprepitant in Japanese Patients with Thoracic Malignancies Who Truly Need It.2015
Author(s)
Ito S, Tsukiyama I, Ando M, Katakami M, Hamanaka R, Kosaka K, Matsubara A, Nishimura M, Tanaka H, Asai N, Yokoe N, Takahashi A, Baba K, Matsuura K, Yamaguchi E, Kubo A.
-
Journal Title
Support Care Cancer
Volume: 23
Issue: 4
Pages: 905-12
DOI
Related Report
Peer Reviewed
-
[Journal Article] The role of smoking status on the progression-free survival of non-small-cell lung cancer patients harboring activating epidermal growth factor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor: a meta-analysis of prospective randomized trials.2015
Author(s)
Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa S, Saka H, Kubo A, Kawaguchi T, Takada M, Rosell R, Kurata T, Ou SH.
-
Journal Title
The Oncologist
Volume: 20
Issue: 3
Pages: 1-9
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Haloperidol Prophylaxis is not Effective for Preventing Postoperative Delirium in Elderly Patients: A Randomized, Open-label Prospective Trial2014
Author(s)
Fukata S, kawabata Y, Fujisiro K, Katagawa Y, Kuroiwa K, Akiyama H, Terabe Y, Ando M, Kawamura T, and Hattori H
-
Journal Title
Surg Today
Volume: 44
Issue: 12
Pages: 2305-2313
DOI
Related Report
Peer Reviewed
-
[Journal Article] Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small cell lung cancer: Docetaxel and Erlotinib Lung cancer TriAl (DELTA).2014
Author(s)
Kawaguchi T, Ando M, Asami K, Okano Y, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A.
-
Journal Title
J Clin Oncol
Volume: 32
Issue: 18
Pages: 1902-8
DOI
Related Report
Peer Reviewed
-
[Journal Article] First-line gefitinib therapy for elderly patients with non-small cell lung cancer harboring EGFR mutation: Central Japan Lung Study Group 09012014
Author(s)
Takahashi K, Saito H, Hasegawa Y, Ando M, Yamamoto M, Kojima E, Sugino Y, Kimura T, Nomura F, Ogasawara T, Shindoh J, Yoshida N, and Suzuki R
-
Journal Title
Cancer Chemother Pharmacol
Volume: 74
Issue: 4
Pages: 721-727
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] A phase III study comparing amrubicin and cisplatin with irinotecan and cisplatin for the treatment of extensive-disease small cell lung cancer (ED-SCLC): JCOG05092014
Author(s)
Satouchi M, Kotani Y, Shibata T, Ando M, Nakagawa K, Yamamoto N, Ichinose Y, Ohe Y, Nishio M, Hida T, Takeda K, Kimura T, Minato K, Akira Y, Atagi S, Fukuda H, Tamura T, and Saijo N
-
Journal Title
J Clin Oncol
Volume: 32
Issue: 12
Pages: 1262-1268
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Efficacy and safety analysis by histology of S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small cell lung cancer: Updated results of a West Japan Oncology Group LETS study2013
Author(s)
Yoshioka H, Okamoto I,Morita S, Ando M, Takeda K, Seto T, Yamamoto N, HideoSaka, Asami K, Hirashima T, Kudoh S,Satouchi M, Ikeda N, Iwamoto Y, Sawa T, Nakanishi Y, and Nakagawa K
-
Journal Title
Ann Oncol
Volume: 24
Issue: 5
Pages: 1326-1331
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer: Results of West Japan Oncology Group (WJOG) Study 3906L2013
Author(s)
Kogure Y, Ando M, Saka H, Chiba Y, Yamamoto N, Asami K, Hirashima T, Seto T, Nagase S, Otsuka K, Yanagihara K, Takeda K, Okamoto I, Aoki T, Takayama K, Yamasaki M, Kudoh S, Katakami N, Miyazaki M, and Nakagawa K
-
Journal Title
J Thorac Oncol
Volume: 8
Issue: 6
Pages: 753-758
DOI
Related Report
Peer Reviewed
-
[Journal Article] A phase III study of laparoscopy assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer (JCOG0912)2013
Author(s)
Nakamura K, Katai H, Mizusawa J, Yoshikawa T, Ando M, Terashima M, Itoh S, Takagi M, Takagane A, Ninomiya M, Fukushima N, and Sasako M
-
Journal Title
Jpn J Clin Oncol
Volume: 43
Issue: 3
Pages: 324-327
DOI
Related Report
Peer Reviewed
-
[Presentation] Can we predict serious adverse events (SAEs) and clarify unfit population for platinum-based chemotherapy in elderly patients (over 70 years of age) with advanced Non-small cell lung cancer (NSCLC)? (CJLSG 1203 trial)2014
Author(s)
Kato Toshio, Morise M, Ando M, Kojima E, Ogasawara T, Suzuki R, Shindoh J, Matsumoto M, Sugino Y, Ogawa M, Nozaki Y, Kondo M, Saito H, and Hasegawa Y
Organizer
European Society for Medical Oncology (ESMO) 2014
Place of Presentation
Madrid, Spain
Year and Date
2014-09-26 – 2014-09-30
Related Report
-
-
[Presentation] Randomized phase III trial of erlotinib (E) versus docetaxel (D) as second- or third-line therapy in patients with advanced non-small cell lung cancer (NSCLC) who have wild-type or mutant epidermal growth factor receptor (EGFR): Docetaxel and Erlotinib Lung Cancer Trial (DELTA).2013
Author(s)
Okano Y, Kawaguchi T, Ando M, Asami K, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, and Kubo A
Organizer
Annual Meeting of American Society of Clinical Oncology
Place of Presentation
シカゴ、アメリカ合衆国
Related Report